- Home
- PCRX
as 11-15-2024 3:38pm EST
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | TAMPA |
| Market Cap: | 604.7M | IPO Year: | 2011 |
| Target Price: | $26.60 | AVG Volume (30 days): | 545.3K |
| Analyst Decision: | Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.96 | EPS Growth: | N/A |
| 52 Week Low/High: | $11.16 - $35.95 | Next Earning Date: | 11-06-2024 |
| Revenue: | $694,957,000 | Revenue Growth: | 4.40% |
| Revenue Growth (this year): | 4.59% | Revenue Growth (next year): | -5.36% |
Latest Pacira BioSciences Inc. News
PCRX Breaking Stock News: Dive into PCRX Ticker-Specific Updates for Smart Investing
GlobeNewswire
3 days ago
Pacira Announces 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee
Argus Research
4 days ago
PCRX: Lowering target price to $13.00
GlobeNewswire
5 days ago
Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences
Argus Research
6 days ago
Daily – Vickers Top Insider Picks for 11/11/2024
Argus Research
9 days ago
Daily – Vickers Top Insider Picks for 11/08/2024
Zacks
10 days ago
Pacira Q3 Earnings Top, Revenues Miss Despite Exparel Sales Growth
Thomson Reuters StreetEvents
10 days ago
Q3 2024 Pacira Biosciences Inc Earnings Call
Argus Research
10 days ago
Daily – Vickers Top Insider Picks for 11/07/2024
Compare PCRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PCRX Pacira BioSciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.